Quijano, Julito C.

HRN: 22-69-64  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2023
CO-AMOXICLAV 625MG (TAB)
03/05/2023
03/12/2023
PO
500 MG
BID
Abrasions
Waiting Final Action 
03/08/2023
CO-AMOXICLAV 625MG (TAB)
03/08/2023
03/11/2023
PO
625mg
TID
Abrasions
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: